Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
PARD stock price ended at $0 on Lundi, after rising NaN%
On the latest trading day Dec 15, 2025, the stock price of PARD rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 54 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 196 shares were traded, equating to a market value of approximately --.
Signaux Techniques de PARD
Résumé des Signaux Techniques
Acheter des signaux 0
Signaux neutres 6
Signaux de vente 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
PARD présente actuellement 0 signaux d'achat et 1 signaux de vente. L'action est en tendance haussière depuis 12:00 AM, avec une variation totale du prix de -- pendant cette période. En général, les indicateurs techniques indiquent une tendance Sell à moyen terme.
Signaux haussiers/baissiers pour PARD
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour PARD, vous aidant à prendre des décisions d'investissement éclairées.
Questions complémentaires
Comment les indicateurs d'analyse technique s'appliquent-ils à PARD ?
Quel est le RSI de Poniard Pharmaceuticals Inc ?
Quel est le prix de Poniard Pharmaceuticals Inc pour les 12 prochains mois ?